Previous Close | 2.8200 |
Open | 2.1500 |
Bid | 0.9500 |
Ask | 4.7000 |
Strike | 30.00 |
Expire Date | 2024-08-16 |
Day's Range | 2.1500 - 2.1500 |
Contract Range | N/A |
Volume | |
Open Interest | 50 |
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale of 5,012 shares of the company on June 11, 2024, as reported in a recent SEC Filing.
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, In
Investors in Pacira BioSciences, Inc. ( NASDAQ:PCRX ) had a good week, as its shares rose 9.3% to close at US$29.86...